| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 901 | 2022 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 718 | 2021 |
| The immunology of sepsis S Sriskandan, DM Altmann The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 390 | 2008 |
| Mammalian Toll-like receptors: to immunity and beyond PA Hopkins, S Sriskandan Clinical & Experimental Immunology 140 (3), 395-407, 2005 | 339 | 2005 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 281 | 2021 |
| Gram-positive sepsis: mechanisms and differences from gram-negative sepsis S Sriskandan, J Cohen Infectious disease clinics of North America 13 (2), 397-412, 1999 | 246 | 1999 |
| Specific C-Terminal Cleavage and Inactivation of Interleukin-8 by Invasive Disease Isolates of Streptococcus pyogenes RJ Edwards, GW Taylor, M Ferguson, S Murray, N Rendell, A Wrigley, ... The Journal of infectious diseases 192 (5), 783-790, 2005 | 242 | 2005 |
| The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing AS Zinkernagel, AM Timmer, MA Pence, JB Locke, JT Buchanan, ... Cell host & microbe 4 (2), 170-178, 2008 | 218 | 2008 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 207 | 2021 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The Lancet Respiratory Medicine 9 (7), 699-711, 2021 | 164 | 2021 |
| Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis HA Jones, S Sriskandan, AM Peters, NB Pride, T Krausz, AR Boobis, ... European Respiratory Journal 10 (4), 795-803, 1997 | 163 | 1997 |
| The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm L Faulkner, A Cooper, C Fantino, DM Altmann, S Sriskandan The Journal of Immunology 175 (10), 6870-6877, 2005 | 151 | 2005 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 142 | 2021 |
| A prenylated dsRNA sensor protects against severe COVID-19 A Wickenhagen, E Sugrue, S Lytras, S Kuchi, M Noerenberg, ML Turnbull, ... Science 374 (6567), eabj3624, 2021 | 141 | 2021 |
| Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis T Parks, C Wilson, N Curtis, A Norrby-Teglund, S Sriskandan Clinical Infectious Diseases 67 (9), 1434-1436, 2018 | 129 | 2018 |
| Superantigens and streptococcal toxic shock syndrome T Proft, S Sriskandan, L Yang, JD Fraser Emerging infectious diseases 9 (10), 1211, 2003 | 129 | 2003 |
| Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom CE Turner, J Abbott, T Lamagni, MTG Holden, S David, MD Jones, ... MBio 6 (4), 10.1128/mbio. 00622-15, 2015 | 128 | 2015 |
| Frequency of epitope-specific naive CD4+ T cells correlates with immunodominance in the human memory repertoire WW Kwok, V Tan, L Gillette, CT Littell, MA Soltis, RB LaFond, J Yang, ... The Journal of Immunology 188 (6), 2537-2544, 2012 | 127 | 2012 |
| Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study NN Lynskey, E Jauneikaite, HK Li, X Zhi, CE Turner, M Mosavie, ... The Lancet Infectious Diseases 19 (11), 1209-1218, 2019 | 126 | 2019 |
| HLA class II polymorphisms determine responses to bacterial superantigens M Llewelyn, S Sriskandan, M Peakman, DR Ambrozak, DC Douek, ... The Journal of Immunology 172 (3), 1719-1726, 2004 | 123 | 2004 |
